EP3133396 - METHODS OF TREATMENT USING AMMONIA-SCAVENGING DRUGS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.07.2019 Database last updated on 26.04.2025 | |
Former | The patent has been granted Status updated on 03.08.2018 | ||
Former | Grant of patent is intended Status updated on 13.03.2018 | ||
Former | Examination is in progress Status updated on 15.09.2017 | ||
Former | Request for examination was made Status updated on 25.08.2017 | ||
Former | The application has been published Status updated on 20.01.2017 | Most recent event Tooltip | 12.07.2019 | No opposition filed within time limit | published on 14.08.2019 [2019/33] | Applicant(s) | For all designated states Immedica Pharma AB Norrtullsgatan 15 113 29 Stockholm / SE | [2019/20] |
Former [2017/28] | For all designated states Horizon Therapeutics, LLC 150 S. Saunders Road Lake Forest, IL 60045 / US | ||
Former [2017/08] | For all designated states Horizon Therapeutics, Inc. 2000 Sierra Point Parkway Suite 400 Brisbane, CA 94005 / US | Inventor(s) | 01 /
SCHARSCHMIDT, Bruce Hyperion Therapeutics 601 Gateway Boulevard Suite 200 South San Francisco, CA 94080 / US | [2017/08] | Representative(s) | Zacco Sweden AB P.O. Box 5581 Löjtnantsgatan 21 114 85 Stockholm / SE | [N/P] |
Former [2017/08] | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | Application number, filing date | 16176456.8 | 07.01.2009 | [2017/08] | Priority number, date | US20080093234P | 29.08.2008 Original published format: US 93234 P | [2017/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3133396 | Date: | 22.02.2017 | Language: | EN | [2017/08] | Type: | B1 Patent specification | No.: | EP3133396 | Date: | 05.09.2018 | Language: | EN | [2018/36] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.11.2016 | Classification | IPC: | G01N33/50 | [2017/08] | CPC: |
A61K31/19 (EP,GB,US);
A61K31/216 (US);
A61K31/192 (GB,US);
A61P13/00 (EP);
A61P3/00 (EP);
G01N33/6812 (EP,GB,US);
G01N33/6893 (EP,GB,US);
G01N2800/085 (EP,US);
G01N2800/347 (EP,US);
G01N2800/52 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2017/39] |
Former [2017/08] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | VERFAHREN ZUR BEHANDLUNG UNTER VERWENDUNG VON AMMONIAKREINIGENDEN WIRKSTOFFEN | [2017/08] | English: | METHODS OF TREATMENT USING AMMONIA-SCAVENGING DRUGS | [2017/08] | French: | PROCÉDÉS DE TRAITEMENT À L'AIDE DE MÉDICAMENTS DÉSACTIVANT L'AMMONIAC | [2017/08] | Examination procedure | 27.06.2016 | Date on which the examining division has become responsible | 22.08.2017 | Amendment by applicant (claims and/or description) | 22.08.2017 | Examination requested [2017/39] | 13.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 17.01.2018 | Reply to a communication from the examining division | 14.03.2018 | Communication of intention to grant the patent | 20.07.2018 | Fee for grant paid | 20.07.2018 | Fee for publishing/printing paid | 20.07.2018 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP09739263.3 / EP2330892 | Divisional application(s) | EP18192516.5 Application deemed to be withdrawn : 05.10.2018 | Opposition(s) | 06.06.2019 | No opposition filed within time limit [2019/33] | Fees paid | Renewal fee | 27.06.2016 | Renewal fee patent year 03 | 27.06.2016 | Renewal fee patent year 04 | 27.06.2016 | Renewal fee patent year 05 | 27.06.2016 | Renewal fee patent year 06 | 27.06.2016 | Renewal fee patent year 07 | 27.06.2016 | Renewal fee patent year 08 | 27.02.2017 | Renewal fee patent year 09 | 29.01.2018 | Renewal fee patent year 10 | Penalty fee | Additional fee for renewal fee | 31.01.2017 | 09   M06   Fee paid on   27.02.2017 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. |